propafenone has been researched along with Pregnancy in 10 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propafenone is a potent antiarrhythmic agent effective in either supraventricular or ventricular tachyarrhythmias." | 8.79 | Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. ( Boriani, G; Capucci, A, 1995) |
| "Propafenone is a well-known Class 1C antiarrhythmic agent that has sodium channel blocking properties as well as the ability to block 13 other channels and a modest calcium antagonistic effect." | 5.72 | Effect of Rythmol (propafenone HCl) administration during pregnancy in Wistar rats. ( Abd-Allah, ER; Amin, S; Badawy, MA; El Ghareeb, AEW, 2022) |
| "Propafenone is a potent antiarrhythmic agent effective in either supraventricular or ventricular tachyarrhythmias." | 4.79 | Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. ( Boriani, G; Capucci, A, 1995) |
| "Evaluation revealed mitral valve prolapse with minimal mitral regurgitation, and normal left ventricular size and function." | 1.28 | New onset ventricular tachycardia during pregnancy. ( Braverman, AC; Bromley, BS; Rutherford, JD, 1991) |
| "In cases of non-immune hydrops fetalis caused by tachyarrhythmias, the transplacental passage of antiarrhythmic drugs may be hampered." | 1.27 | Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs. ( Bald, R; Gembruch, U; Hansmann, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Allah, ER | 1 |
| Amin, S | 1 |
| El Ghareeb, AEW | 1 |
| Badawy, MA | 1 |
| Basza, M | 1 |
| Maciejewski, C | 1 |
| Bojanowicz, W | 1 |
| Balsam, P | 1 |
| Grabowski, M | 1 |
| Mitkowski, P | 1 |
| Kempa, M | 1 |
| Kowalski, O | 1 |
| Kalarus, Z | 1 |
| Jaguszewski, M | 1 |
| Lubiński, A | 1 |
| Daniłowicz-Szymanowicz, L | 1 |
| Szumowski, Ł | 1 |
| Sterliński, M | 1 |
| Kołtowski, Ł | 1 |
| Moon, JH | 1 |
| Kim, YG | 1 |
| Kim, K | 1 |
| Osonoi, S | 1 |
| Wang, S | 1 |
| Saunders, DC | 1 |
| Wang, J | 1 |
| Yang, K | 1 |
| Kim, H | 2 |
| Lee, J | 1 |
| Jeong, JS | 1 |
| Banerjee, RR | 1 |
| Kim, SK | 1 |
| Wu, Y | 1 |
| Mizukami, H | 1 |
| Powers, AC | 1 |
| German, MS | 1 |
| Bjeloševič, M | 1 |
| Illíková, V | 1 |
| Tomko, J | 1 |
| Olejník, P | 1 |
| Chalupka, M | 1 |
| Hatala, R | 1 |
| Capucci, A | 1 |
| Boriani, G | 1 |
| Braverman, AC | 1 |
| Bromley, BS | 1 |
| Rutherford, JD | 1 |
| Libardoni, M | 1 |
| Piovan, D | 1 |
| Busato, E | 1 |
| Padrini, R | 1 |
| Gembruch, U | 1 |
| Hansmann, M | 1 |
| Bald, R | 1 |
| Brunozzi, LT | 1 |
| Meniconi, L | 1 |
| Chiocchi, P | 1 |
| Liberati, R | 1 |
| Zuanetti, G | 1 |
| Latini, R | 1 |
| Santinelli, V | 1 |
| de Paola, M | 1 |
| Turco, P | 1 |
| Smimmo, D | 1 |
| Chiariello, M | 1 |
| Condorelli, M | 1 |
2 reviews available for propafenone and Pregnancy
| Article | Year |
|---|---|
Flecainide in clinical practice.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Child; Female; Flecainide; Humans; Pregnancy; Propafeno | 2023 |
Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Electrophysiology; Female; | 1995 |
8 other studies available for propafenone and Pregnancy
| Article | Year |
|---|---|
Effect of Rythmol (propafenone HCl) administration during pregnancy in Wistar rats.
Topics: Animals; Anti-Arrhythmia Agents; Female; Humans; Placenta; Pregnancy; Propafenone; Rats; Rats, Wista | 2022 |
Serotonin Regulates Adult β-Cell Mass by Stimulating Perinatal β-Cell Proliferation.
Topics: Animals; Animals, Newborn; Cell Proliferation; Female; Glucose; Growth Hormone; Humans; Infant; Insu | 2020 |
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Pregna | 2020 |
New onset ventricular tachycardia during pregnancy.
Topics: Adult; Electrocardiography; Electrophysiology; Female; Humans; Mitral Valve Insufficiency; Mitral Va | 1991 |
Transfer of propafenone and 5-OH-propafenone to foetal plasma and maternal milk.
Topics: Adult; Animals; Female; Fetal Blood; Humans; Maternal-Fetal Exchange; Milk; Pregnancy; Propafenone | 1991 |
Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Female; Fetal Diseases; Flecainide; Humans; Hydrops Fetalis; Medigoxin; Preg | 1988 |
Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient.
Topics: Adult; Arrhythmias, Cardiac; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pro | 1988 |
Wolff-Parkinson-White at risk and propafenone.
Topics: Administration, Oral; Adult; Female; Humans; Pregnancy; Propafenone; Wolff-Parkinson-White Syndrome | 1988 |